Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs.

J Mol Biol. 1996 Mar 29;257(2):246-64. Unique Identifier : AIDSLINE MED/96180013
Mikaelian I; Krieg M; Gait MJ; Karn J; MRC Laboratory of Molecular Biology, Cambridge, UK.


Abstract: The human immunodeficiency virus type (HIV-1) Rev protein stimulates the export to the cytoplasm of unspliced HIV-1 mRNAs carrying the Rev response element (RRE). However, simple addition of the RRE to beta-globin pre-mRNA does not confer a Rev response on this heterologous transcript. In this paper, we demonstrate that a strong Rev response is conferred on beta-globin pre-mRNA when an inhibitory (INS) element is inserted into the gene together with the RRE. In the presence of INS element, Rev was able to stimulate the export to the cytoplasm of unspliced mRNA 10 to 15-fold. INS elements from the HIV-1 p17 gag and pol genes were equally active in complementing Rev-dependent nuclear export of unspliced mRNA. By contrast, mutated p17 gag INS element, known to be inactive in gag mRNA instability assays, was unable to complement the Rev/RRE system and stimulate nuclear export. Similarly, AUUUA-instability elements from the granulocyte-macrophage colony stimulating factor mRNA (GM-CSF) destabilised beta-globin mRNA but could not substitute for the HIV INS elements. Complementation between the Rev/RRE system and the INS elements was only observed when splicing was efficient. When splicing of the beta-globin gene receptor is impaired by mutations in the 5' splice donor, the 3' splice acceptor sequence, or the polypyrimidine tract, the majority of the unspliced mRNA is exported from the nucleus in the absence of Rev. In the presence of splice site mutations, Rev is able to act independently of a functional INS element and increase the export of unspliced mRNA three to fivefold. We propose that nuclear factor(s) binding to INS elements separate unspliced beta-globin pre-mRNA from the splicing apparatus. Pre-mRNA in this INS compartment remains accessible to Rev. Thus, there is a synergy between the INS elements and Rev which leads to enhanced nuclear export of unspliced mRNA.
Keywords: Animal Base Sequence Cell Nucleus/METABOLISM Cytoplasm/METABOLISM Gene Expression Gene Products, gag/GENETICS Gene Products, rev/*GENETICS Genes, gag/GENETICS Genes, pol/GENETICS Genes, Reporter/GENETICS Genetic Complementation Test Globin/GENETICS Granulocyte-Macrophage Colony-Stimulating Factor/GENETICS Hela Cells Human HIV Antigens/GENETICS HIV-1/*GENETICS/METABOLISM Models, Genetic Molecular Sequence Data Mutation Rabbits Regulatory Sequences, Nucleic Acid/*GENETICS RNA Precursors/*METABOLISM RNA Splicing/*GENETICS Support, Non-U.S. Gov't JOURNAL ARTICLEKWDanimalbasesequencecellnucleus/metabolismcytoplasm/metabolismgeneexpressiongeneproducts,gag/geneticsgeneproducts,rev/KWDgeneticsgenes,gag/geneticsgenes,pol/geneticsgenes,reporter/geneticsgeneticcomplementationtestglobin/geneticsgranulocyte-macrophagecolony-stimulatingfactor/geneticshelacellshumanhivantigens/geneticshiv-1/KWDgenetics/metabolismmodels,geneticmolecularsequencedatamutationrabbitsregulatorysequences,nucleicacid/KWDgeneticsrnaprecursors/KWDmetabolismrnasplicing/KWDgeneticssupport,non-uKWDsKWDgov'tjournalarticle
960830
M9681175

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .